Amedisys — Investor Presentation (January 2021)
15 slides from Amedisys's investor presentation, Jan 13, 2021
Slide 1: Amedisys Strategy 2021 & Beyond
Amedisys Strategy 2021 & Beyond Exhibit 99.1
Slide 2: Forward-looking statements
This presentation may include forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon current expectations and assumptions about our business that are subject to a variety of risks and uncertainties that could cau
Slide 3: Why Do We Believe Our Future Is Bright?
Accelerating demographic growth in our core businesses; beneficial psychographics with aging Baby Boomers; favorable future regulatory market basket updates for both Home Health and Hospice; highly- fragmented industry sectors and strong cash flow for consolidation; preferred and safest site of care
Slide 4: Market Forces: Demographics – Major Tailwinds
The rapid growth of the 75+ population, our target demographic (4.4% CAGR from 2018 - 2030), is poised to drive increased demand for home health, hospice and personal care services as this chronically-ill population has moved from acute, episodic disease to long-term, chronic illness. Baby Boomers a
Slide 5: Market Forces: Psychographics / Consumer Preferences
The transition from high-impact (acute) to high-touch / low-impact (chronic) care delivery places home health at the forefront for clinical care and ecosystem disruption. Customers want it, economics will dictate it, and technology tools and training will better enable it Market Forces: Psychographi
Slide 6: Market Forces: Economics of Home Health, Hospice and Personal Care
Home Health, Hospice and Personal Care represent the most cost effective and most consumer-desired settings and services. Discharges without care (“Direct to Home”) represent an opportunity for Personal Care and Home Health to act as a driver to reduce re-hospitalizations as Home Health is able to t
Slide 7: Market Forces: Regulatory & Reimbursement Outlook - Payment Forecasting
Annually, we validate a five-year projection for Medicare fee-for-service (FFS) payment updates for both Home Health and Hospice. These projections are based on (1) the projected market basket updates as published quarterly by CMS, and (2) past Multifactor Productivity Adjustments (“MPA”) that have
Slide 8: Market Forces: Post-COVID Landscape – Opportunity for Share Gains Through Consolidation
Impact of PDGM (no-Pay Request for Anticipated Payment) and required CARES Act stimulus repayments (accelerated/advanced payments, payroll tax deferral repayment and sequestration suspension expiration 3/31/21) create further hurdles for smaller industry competitors. Market Forces: Post-COVID Landsc
Slide 9: Market Forces: Anticipated Segment Growth
Home Health utilization has grown at ~2% annually over the past few years and is projected to have a CAGR of ~6% between 2021 and 2027. Hospice utilization has grown ~4.5% over the past few years and is projected to have a CAGR of ~7% between 2021 and 2027 (these projections do not consider Hospice
Slide 10: Market Forces: Home Health and Hospice Market Share Gains
AMED has an opportunity to gain significant market share organically and inorganically. PDGM and COVID-19 should accelerate consolidation in Home Health in 2021-2022. With continued strong cash flow, AMED could spend over $350M on M&A while maintaining a low (1.0x) leverage ratio. Today, 90% of home
Slide 11: Strategic Response: Our Future Focus Remains Largely The Same
Expanding and executing on 2020 initiatives extends to our key focus areas for 2021 and beyond. Preparing for outsized growth, continued M&A industry disruption / consolidation, integration of new assets and close-to-core innovations will be our areas of focus Optimize current PCL Business, Operatio
Slide 12: Strategic Response: Focus On The Strategic Pillars Has Delivered Strong Results
Strategic Response: Focus On The Strategic Pillars Has Delivered Strong Results to Date Performance across all lines of business has significantly improved. Growth & Margin expansion (consolidated and in all three lines of business) has been an impressive story. “Same Game – Better” with “Close-to-C
Slide 13: Strategic Response: Looks Good to Us – You Do the Math
Strategic Response: Looks Good to Us – You Do the Math Building blocks for future EBITDA growth – the future looks bright
Slide 14: Summary Takeaways from Amedisys 2021 Strategy
Summary Takeaways from Amedisys 2021 strategy Market forces are very strong and largely in our favor for next 5-7 years The market is moving towards the home. Our businesses are in the highest growth areas in healthcare Our ability to plan and execute quickly has given us advantages in a tumultuous
Slide 15: Citations
Citations Demographic Info: https://www.prb.org/aging-unitedstates-fact-sheet/ https://www.aarp.org/research/topics/community/info-2018/2018-home-community-preference.html#:~:text=While%2076%25%20of%20Americans%20age,within%20their%20community%20(13%25). Home Health Industry Info: https://www.health